GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ace (ACE) [hlAlert]

Rating:
Outperform
ACE
up 26.32 %

Ace (ACE) rated Outperform by Wells Fargo

Posted on: Thursday,  Jan 10, 2013  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Ace (NYSE: ACE) on 01/10/2013, when the stock price was $82.04. Since
then, Ace has gained 26.33% as of 01/05/2016's recent price of $103.64.
If you would have followed this Wells Fargo's recommendation on ACE, you would have gained 26.32% of your investment in 1090 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/10/2013 8:25 AM Buy
None
82.04
as of 12/13/2013
1 Week down  -2.63 %
1 Month up  2.01 %
3 Months up  8.27 %
1 YTD up  20.98 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy